BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Archimedes Pharma 

250 South Oak Way
Green Park
Reading    RG2 6UG  United Kingdom
Phone: 44-0-118-931-5050 Fax: 44-0-118-931-5051


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Depomed, Inc. (DEPO) Announces Acquisition of Lazanda® (fentanyl) Nasal Spray From Archimedes Pharma 7/30/2013 7:55:11 AM
Pharmalink AB Gains Exclusive Licence to Archimedes Pharma's TARGIT(R) Technology for Nefecon(R) (PL-56) Program 12/13/2011 10:13:24 AM
Archimedes Pharma Launches Lazanda(R) - the Only Fentanyl Nasal Spray for the Management of Breakthrough Pain in Cancer in the U.S. 10/17/2011 11:32:08 AM
FDA Approves Archimedes Pharma's Lazanda(R) - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients 7/1/2011 6:38:49 AM
Archimedes Pharma Announces Publication of Long-Term Safety and Tolerability Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in the Journal of Opioid Management 10/12/2010 11:42:09 AM
Archimedes Pharma Announces Publication of a Pivotal Clinical Study of Fentanyl Pectin Nasal Spray (FPNS) in Pain, the Peer-Reviewed Journal from the International Association for the Study of Pain 10/4/2010 7:37:08 AM
EC Regulator Rubber-Stamps Archimedes Pharma’s Intranasal Fentanyl Spray for Cancer Pain 9/1/2010 6:24:22 AM
Archimedes Pharma Announces New US Headquarters In Bedminster, New Jersey; Archimedes Given Grant To Create Up to 75 New Jobs 8/23/2010 7:57:43 AM
Genetic Technologies Limited (GTG.AX) Announces Archimedes Pharma's BREVAGen(TM) Pharmacoeconomic Data Presented at American Society of Clinical Oncology 2010 in Chicago 6/8/2010 10:58:32 AM
Private UK Drug Firm Archimedes Pharma Raises US $100 Million; Former Enzon Pharmaceuticals, Inc. (ENZN) Head Appointed as CEO; US Commercial Operations to be Established 3/2/2010 6:57:09 AM
123